GB-5112

GB-5112
Product Description

Duration / Indication: 1-Month / Alzheimer’s disease
Development Status: Lead-optimization

Read more Show less

G2GBIO

  • KR
  • 2019
    On CPHI since
View company profile
Categories
more categories Show less

G2GBIO

  • KR
  • 2019
    On CPHI since
View company profile

More Products from G2GBIO (2)

  • InnoLAMP Technology

    Product InnoLAMP Technology

    G2GBIO specializes in developing long acting microsphere products. We have been developing unique InnoLAMP technology which can make monodisperse PLGA, PLA or PCL microspheres for long acting drugs or dermal filler.
    What Makes Us Different?
    Precise Size & Release Control
    Our propri...
  • GB-5001

    Product GB-5001

    Duration / Indication: 1-Month / Alzheimer’s disease
    Development Status: Nonclinical